🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This Phase II study is a monocenter, long-term extension study of study GNC...
Status
Terminated
Location
Center for Neurology, Academic Specialist Center
Start Date
2021-08-27
Trial ID
NCT05049161
Treatments Being Tested
The humanised IgG4 monoclonal antibody GNbAC1 targets the envelope protein ...
Status
Terminated
Location
Hospital
Start Date
2017-06-06
Trial ID
NCT03239860
Treatments Being Tested
This is a phase I, double-blind, placebo controlled, parallel group, dose-e...
Status
Completed
Location
Scientia Clinical Research Ltd
Start Date
2018-05-08
Trial ID
NCT03574428
Treatments Being Tested
In this clinical study, the safety and tolerability of GNbAC1 as a treatmen...
Status
Completed
Location
PAREXEL Early Phase Clinical Unit
Start Date
2015-04
Trial ID
NCT02452996
Treatments Being Tested
The purpose of this study is to assess the safety and tolerability of singl...
Status
Completed
Location
Multiple Locations
Start Date
2011-07
Trial ID
NCT01699555
Treatments Being Tested
The purpose of this study is to assess the safety and tolerability of singl...
Status
Completed
Location
University Hospital Basel
Start Date
2012-07
Trial ID
NCT01639300
Treatments Being Tested
Randomized, double-blind, placebo-controlled Phase IIa clinical study, asse...
Status
Completed
Location
Center for Neurology, Academic Specialist Center
Start Date
2020-06-17
Trial ID
NCT04480307
Treatments Being Tested
This study is a Phase 2, 24-week, randomized, prospective, double-blind, mu...
Status
Completed
Location
Clinica Metabolica dell'Università di Modena e Reggio Emilia
Start Date
2022-08-29
Trial ID
NCT05497089
Treatments Being Tested
The humanised IgG4 monoclonal antibody GNbAC1 targets the envelope protein ...
Status
Completed
Location
Multiple Locations
Start Date
2016-04
Trial ID
NCT02782858
The monoclonal antibody GNbAC1 targets the envelope protein (Env) of the hu...
Status
Completed
Location
Macquarie University Hospital
Start Date
2017-06-14
Trial ID
NCT03179423